Literature DB >> 20439480

Complement receptor 1 expression on mouse erythrocytes mediates clearance of Streptococcus pneumoniae by immune adherence.

Jie Li1, Jennifer P Wang, Ionita Ghiran, Anna Cerny, Alexander J Szalai, David E Briles, Robert W Finberg.   

Abstract

Complement-containing immune complexes can be presented to phagocytes by human erythrocytes bearing complement receptor 1 (CR1). Although this has long been assumed to be a mechanism by which humans are able to protect themselves from "extracellular" bacteria such as pneumococci, there is little direct evidence. In these studies we have investigated this question by comparing results for erythrocytes from transgenic mice expressing human CR1 on their erythrocytes to the results for wild-type mouse erythrocytes that do not express CR1. We demonstrate that human CR1 expression on murine erythrocytes allows immune adherence to beads opsonized with either mouse or human serum as a source of complement. The role of CR1 in immune adherence was supported by studies showing that it was blocked by the addition of antibody to human CR1. Furthermore, human CR1 expression enhances the immune adherence of opsonized pneumococci to erythrocytes in vitro, and the pneumococci attached to erythrocytes via CR1 can be transferred in vitro to live macrophages. Even more importantly, we observed that if complement-opsonized pneumococci are injected intravenously with CR1(+) mouse erythrocytes into wild-type mice (after a short in vitro incubation), they are cleared faster than opsonized pneumococci similarly injected with wild-type mouse erythrocytes. Finally, we have shown that the intravenous (i.v.) injection of pneumococci into CR1(+) mice also results in more rapid blood clearance than in wild-type mice. These data support that immune adherence via CR1 on erythrocytes likely plays an important role in the clearance of opsonized bacteria from human blood.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20439480      PMCID: PMC2897369          DOI: 10.1128/IAI.01263-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

Review 1.  How are immune complexes bound to the primate erythrocyte complement receptor transferred to acceptor phagocytic cells?

Authors:  A Nardin; M A Lindorfer; R P Taylor
Journal:  Mol Immunol       Date:  1999 Sep-Oct       Impact factor: 4.407

Review 2.  Immune adherence revisited: novel players in an old game.

Authors:  Christoph Hess; Jürg A Schifferli
Journal:  News Physiol Sci       Date:  2003-06

3.  The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice.

Authors:  Jeremy S Brown; Tracy Hussell; Sarah M Gilliland; David W Holden; James C Paton; Michael R Ehrenstein; Mark J Walport; Marina Botto
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-11       Impact factor: 11.205

Review 4.  CR1 and CR1-like: the primate immune adherence receptors.

Authors:  D J Birmingham; L A Hebert
Journal:  Immunol Rev       Date:  2001-04       Impact factor: 12.988

5.  Concerted clearance of immune complexes bound to the human erythrocyte complement receptor: development of a heterologous mouse model.

Authors:  Andrea L Henderson; Margaret A Lindorfer; Adam D Kennedy; Patricia L Foley; Ronald P Taylor
Journal:  J Immunol Methods       Date:  2002-12-15       Impact factor: 2.303

6.  Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface.

Authors:  Bing Ren; Alexander J Szalai; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae.

Authors:  David E Briles; Susan K Hollingshead; James C Paton; Edwin W Ades; Lea Novak; Frederik W van Ginkel; William H Benjamin
Journal:  J Infect Dis       Date:  2003-07-14       Impact factor: 5.226

8.  Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.

Authors:  D T Fearon
Journal:  J Exp Med       Date:  1980-07-01       Impact factor: 14.307

9.  Identification of an active disaccharide unit of a glycoconjugate receptor for pneumococci attaching to human pharyngeal epithelial cells.

Authors:  B Andersson; J Dahmén; T Frejd; H Leffler; G Magnusson; G Noori; C S Edén
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

10.  Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1.

Authors:  Robert C Carlisle; Ying Di; Anna M Cerny; Andreas F-P Sonnen; Robert B Sim; Nicola K Green; Vladimir Subr; Karel Ulbrich; Robert J C Gilbert; Kerry D Fisher; Robert W Finberg; Leonard W Seymour
Journal:  Blood       Date:  2009-01-08       Impact factor: 22.113

View more
  17 in total

1.  Neisseria meningitidis and Escherichia coli are protected from leukocyte phagocytosis by binding to erythrocyte complement receptor 1 in human blood.

Authors:  Ole-Lars Brekke; Bernt Christian Hellerud; Dorte Christiansen; Hilde Fure; Albert Castellheim; Erik Waage Nielsen; Anne Pharo; Julie Katrine Lindstad; Grethe Bergseth; Graham Leslie; John D Lambris; Petter Brandtzaeg; Tom Eirik Mollnes
Journal:  Mol Immunol       Date:  2011-08-11       Impact factor: 4.407

2.  Complement receptor activity of recombinant porcine CR1-like protein expressed in a eukaryotic system.

Authors:  Wei Yin; Xiaoming Wei; Junbing Jiang; Kuohai Fan; Junxing Zhao; Na Sun; Zhiwei Wang; Yaogui Sun; Haili Ma; Xin Zhao; Hongquan Li
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

3.  Complement receptor 1 gene variants are associated with erythrocyte sedimentation rate.

Authors:  Iftikhar J Kullo; Keyue Ding; Khader Shameer; Catherine A McCarty; Gail P Jarvik; Joshua C Denny; Marylyn D Ritchie; Zi Ye; David R Crosslin; Rex L Chisholm; Teri A Manolio; Christopher G Chute
Journal:  Am J Hum Genet       Date:  2011-06-23       Impact factor: 11.025

Review 4.  CR1 in Alzheimer's disease.

Authors:  Xi-Chen Zhu; Jin-Tai Yu; Teng Jiang; Ping Wang; Lei Cao; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-05-04       Impact factor: 5.590

5.  Bio-inspired cryo-ink preserves red blood cell phenotype and function during nanoliter vitrification.

Authors:  Rami El Assal; Sinan Guven; Umut Atakan Gurkan; Irep Gozen; Hadi Shafiee; Sedef Dalbeyler; Noor Abdalla; Gawain Thomas; Wendy Fuld; Ben M W Illigens; Jessica Estanislau; Joseph Khoory; Richard Kaufman; Claudia Zylberberg; Neal Lindeman; Qi Wen; Ionita Ghiran; Utkan Demirci
Journal:  Adv Mater       Date:  2014-07-22       Impact factor: 30.849

6.  Differential impact of respiratory syncytial virus and parainfluenza virus on the frequency of acute otitis media is explained by lower adaptive and innate immune responses in otitis-prone children.

Authors:  David Verhoeven; Qingfu Xu; Michael E Pichichero
Journal:  Clin Infect Dis       Date:  2014-04-29       Impact factor: 9.079

7.  Phagocytic dysfunction of human alveolar macrophages and severity of chronic obstructive pulmonary disease.

Authors:  Charles S Berenson; Ragina L Kruzel; Ellana Eberhardt; Sanjay Sethi
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

8.  Mice expressing human CR1/CD35 have an enhanced humoral immune response to T-dependent antigens but fail to correct the effect of premature human CR2 expression.

Authors:  Isabel Y Pappworth; Christine Hayes; Jason Dimmick; B Paul Morgan; V Michael Holers; Kevin J Marchbank
Journal:  Immunobiology       Date:  2011-06-25       Impact factor: 3.144

9.  The efficacy of pneumococcal capsular polysaccharide-specific antibodies to serotype 3 Streptococcus pneumoniae requires macrophages.

Authors:  Kevin Fabrizio; Catherine Manix; Haijun Tian; Nico van Rooijen; Liise-anne Pirofski
Journal:  Vaccine       Date:  2010-08-26       Impact factor: 3.641

Review 10.  Complement-Mediated Events in Alzheimer's Disease: Mechanisms and Potential Therapeutic Targets.

Authors:  Andrea J Tenner
Journal:  J Immunol       Date:  2020-01-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.